Testing effectiveness (Phase 2)UnknownNCT00004315
What this trial is testing
Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
Who this might be right for
Cystic FibrosisGastrointestinal DiseasesCholestasis
National Center for Research Resources (NCRR) 20